Company

Minaris Regenerative Medicine USA

Minaris Regenerative Medicine provides development and manufacturing services for cell and gene therapies.

About

Minaris Regenerative Medicine supports cell and gene therapies through process development, clinical and commercial manufacturing, and quality control and assurance. The company serves therapies for cancer, genetic disorders and other chronic diseases. Founded in 1999, it is based in New Jersey and is at seed stage. In September 2024, Altaris agreed to acquire it from Resonac Holdings Corporation. CEO Hiroto Bondo was leading the company as of that month.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in